371 related articles for article (PubMed ID: 28334791)
21. Isolated ACTH deficiency during single-agent pembrolizumab for squamous cell lung carcinoma: a case report.
Tanaka S; Kushimoto M; Nishizawa T; Takubo M; Mitsuke K; Ikeda J; Fujishiro M; Ogawa K; Tsujino I; Suzuki Y; Abe M
Clin Diabetes Endocrinol; 2020; 6():1. PubMed ID: 31921440
[TBL] [Abstract][Full Text] [Related]
22. Isolated ACTH deficiency following immunization with the BNT162b2 SARS-CoV-2 vaccine: a case report.
Morita S; Tsuji T; Kishimoto S; Uraki S; Takeshima K; Iwakura H; Furuta H; Nishi M; Inaba H; Matsuoka TA
BMC Endocr Disord; 2022 Jul; 22(1):185. PubMed ID: 35854260
[TBL] [Abstract][Full Text] [Related]
23. [A Case of Isolated ACTH Deficiency Induced by Nivolumab in a Patient with Gastric Cancer Metastasis of the Peritoneum].
Mashita N; Otake K; Nonogaki A; Saito H; Nakamura M; Yamanaka M; Tobinaga J; Ishigure K
Gan To Kagaku Ryoho; 2019 Dec; 46(12):1879-1882. PubMed ID: 31879407
[TBL] [Abstract][Full Text] [Related]
24. Nivolumab-induced hypophysitis causing secondary adrenal insufficiency after transient ACTH elevation.
Sekizaki T; Kameda H; Oba C; Yong Cho K; Nakamura A; Miyoshi H; Osawa T; Shinohara N; Atsumi T
Endocr J; 2019 Oct; 66(10):937-941. PubMed ID: 31217401
[TBL] [Abstract][Full Text] [Related]
25. Isolated adrenocorticotropic hormone deficiency potentially induced by nivolumab following pseudo-progression in clear cell renal cell carcinoma: A case report.
Furubayashi N; Negishi T; Uozumi T; Takamatsu D; Shiraishi K; Hirose D; Nakamura M
Mol Clin Oncol; 2019 Feb; 10(2):304-308. PubMed ID: 30680212
[TBL] [Abstract][Full Text] [Related]
26. Adrenal insufficiency following nivolumab therapy in patients with recurrent or metastatic head and neck cancer.
Kagoshima H; Hori R; Kojima T; Okanoue Y; Fujimura S; Taguchi A; Shoji K
Auris Nasus Larynx; 2020 Apr; 47(2):309-313. PubMed ID: 31235078
[TBL] [Abstract][Full Text] [Related]
27. Isolated Adrenocorticotropin Deficiency Concomitant with Graves' Disease: A Case Report and Literature Review.
Ohara N; Kaneko M; Kuriyama H; Sato K; Katakami H; Oki Y; Kaneko K; Kamoi K
Intern Med; 2016; 55(18):2649-58. PubMed ID: 27629962
[TBL] [Abstract][Full Text] [Related]
28. Identification of the novel autoantigen candidate Rab GDP dissociation inhibitor alpha in isolated adrenocorticotropin deficiency.
Kiyota A; Iwama S; Sugimura Y; Takeuchi S; Takagi H; Iwata N; Nakashima K; Suzuki H; Nishioka T; Kato T; Enomoto A; Arima H; Kaibuchi K; Oiso Y
Endocr J; 2015; 62(2):153-60. PubMed ID: 25346144
[TBL] [Abstract][Full Text] [Related]
29. Fulminant ACTH decrease following diabetic ketoacidosis induced by immune checkpoint inhibitor combination therapy with nivolumab and ipilimumab: A case report.
Iesaka H; Kameda H; Miya A; Nomoto H; Cho KY; Nakamura A; Abe T; Shinohara N; Atsumi T
Medicine (Baltimore); 2023 Dec; 102(51):e36664. PubMed ID: 38134115
[TBL] [Abstract][Full Text] [Related]
30. Isolated adrenocorticotropic hormone deficiency induced by nivolumab treatment for advanced gastric cancer.
Namikawa T; Shimizu S; Yokota K; Tanioka N; Fukudome I; Munekage M; Uemura S; Maeda H; Kitagawa H; Hanazaki K
Clin J Gastroenterol; 2021 Aug; 14(4):988-993. PubMed ID: 33715100
[TBL] [Abstract][Full Text] [Related]
31. Immunotherapy-induced isolated ACTH deficiency in cancer therapy.
Iglesias P; Peiró I; Biagetti B; Paja-Fano M; Cobo DA; García Gómez C; Mateu-Salat M; Genua I; Majem M; Riudavets M; Gavira J; Lamas C; Fernández Pombo A; Guerrero-Pérez F; Villabona C; Cabezas Agrícola JM; Webb SM; Díez JJ
Endocr Relat Cancer; 2021 Oct; 28(12):783-792. PubMed ID: 34609950
[TBL] [Abstract][Full Text] [Related]
32. Immune checkpoint inhibitor-induced isolated adrenocorticotropic hormone deficiency: a systematic review.
Wang F; Shi X; Yu X; Yang Y
Front Endocrinol (Lausanne); 2024; 15():1326684. PubMed ID: 38318292
[TBL] [Abstract][Full Text] [Related]
33. A case of nivolumab-induced isolated adrenocorticotropic hormone (ACTH) deficiency.
Sato Y; Tanaka Y; Hino M; Seike M; Gemma A
Respir Med Case Rep; 2019; 26():223-226. PubMed ID: 30740300
[TBL] [Abstract][Full Text] [Related]
34. May primary empty sella turcica be a cause of isolated ACTH deficiency? A case report and the review of related literature.
Gulcan E; Gulcan A; Taser F; Korkmaz U; Erbilen E
Neuro Endocrinol Lett; 2007 Dec; 28(6):745-8. PubMed ID: 18063931
[TBL] [Abstract][Full Text] [Related]
35. Autoimmune polyendocrine syndrome type 3, characterized by autoimmune thyroid disease, type 1 diabetes mellitus, and isolated ACTH deficiency, developed during adjuvant nivolumab treatment.
Takata M; Nomura M; Yamamura K; Muto M; Komori T; Otsuka A; Kabashima K
Asia Pac J Clin Oncol; 2022 Aug; 18(4):481-482. PubMed ID: 33870636
[TBL] [Abstract][Full Text] [Related]
36. Paraneoplastic autoimmune hypophysitis: An emerging concept.
Bando H; Kanie K; Takahashi Y
Best Pract Res Clin Endocrinol Metab; 2022 May; 36(3):101601. PubMed ID: 34876362
[TBL] [Abstract][Full Text] [Related]
37. A middle aged woman with isolated ACTH deficiency associated with transient growth hormone deficiency.
Hernán Martínez J; Mangual Garcia MM; Gutiérrez Acevedo M; Sánchez Cruz A; Laboy I; Rivera C; Mansilla P; Palermo Garofalo C; Lourdes Miranda M; Torres Rafael O
Bol Asoc Med P R; 2016; 108(1):5-8. PubMed ID: 29192748
[TBL] [Abstract][Full Text] [Related]
38. Corticotropic insufficiency in a monocentric prospective cohort of patients with lung cancer treated with nivolumab: Prevalence and etiology.
Ducloux R; Tavernier JY; Wojewoda P; Toullet F; Romanet S; Averous V
Ann Endocrinol (Paris); 2021 Feb; 82(1):8-14. PubMed ID: 33290748
[TBL] [Abstract][Full Text] [Related]
39. Pituitary-adrenal dysfunction caused by nivolumab for head and neck cancer.
Hihara K; Sato H; Okamoto I; Katsube Y; Maruyama R; Tomioka R; Tanaka H; Tsukahara K
Auris Nasus Larynx; 2019 Dec; 46(6):896-901. PubMed ID: 31350019
[TBL] [Abstract][Full Text] [Related]
40. Neurological symptoms in a patient with isolated adrenocorticotropin deficiency: case report and literature review.
Goto Y; Tatsuzawa K; Aita K; Furuno Y; Kawabe T; Ohwada K; Sasajima H; Mineura K
BMC Endocr Disord; 2016 Jan; 16():2. PubMed ID: 26754976
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
